Trademark Overview
On Friday, December 22, 2023, a trademark application was filed for OMRIVY with the United States Patent and Trademark Office. The USPTO has given the OMRIVY trademark a serial number of 98328201. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, December 22, 2023. This trademark is owned by Cerevel Therapeutics, LLC. The OMRIVY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neuropsychological diseases and disorders; pharmaceutical preparations for the prevention and treatment of medical conditions in the field of neuroscience.